Walgreens Defeats $200M Investor Suit Over Insulin Billing
A Delaware vice chancellor has thrown out a stockholder derivative suit accusing Walgreens directors of ignoring an alleged scheme in which insulin pen prescriptions were overfilled and the government overbilled, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article